References
- Wiysonge CS , BradleyHA, VolminkJ, MayosiBM, MbewuA, OpieLH . Beta-blockers for hypertension . Cochrane Database Syst. Rev.11, CD002003 ( 2012 ).
- Silvestri A , GalettaP, CerquetaniEet al. Report of erectile dysfunction after therapy with betablockers is related to patient knowledge of side- effects and is reversed by placebo . Eur. Heart J.24, 1928 – 1932 ( 2003 ).
- Mancia G , LaurentS, Agabiti-RoseiE, AmbrosioniE, BurnierM, CaulfieldMJ . Re-appraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document . J. Hypertens.27, 2121 – 2158 ( 2009 ).
- Elliott WJ , MeyerPM . Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis . Lancet369, 201 – 207 ( 2007 ).
- Turnbull F1 , NealB, AlgertCet al. ; Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials . Arch. Intern. Med.165, 1410 – 1419 ( 2005 ).
- Law MR , MorrisJK, WaldNJ . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies . BMJ338, b1665 ( 2009 ).
- Mancia G , FagardR, NarkiewiczKet al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) . J. Hypertens.31 ( 7 ), 1281 – 1357 ( 2013 ).
- Bristow MR . Beta-adrenergic receptor blockade in chronic heart failure . Circulation101, 558 – 569 ( 2000 ).
- Giugliano D , MarfellaR, AcamporaR, GiuntaR, CoppolaL, D’OnofrioF . Effects of perindopril and carvedilol on endotheliumdependent vascular functions in patients with diabetes and hypertension . Diabetes Care21, 631 – 636 ( 1998 ).
- Lopez BL , ChristopherTA, YueTL, RuffoloR, FeuersteinGZ, MaXL . Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction . Pharmacology51, 165 – 173 ( 1995 ).
- Bakris GL , FonsecaV, KatholiREet al. Metabolic effects of carvedilol vs metoprolol in patients with Type 2 diabetes mellitus and hypertension: a randomized controlled trial . JAMA292, 2227 – 2236 ( 2004 ).
- Brixius K , BundkirchenA, BölckB . Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium . Br. J. Pharmacol.133, 1330 – 1338 ( 2001 ).
- Dhakam Z , Yasmin, McEnieryCM . A comparison of atenolol and nebivolol in isolated systolic hypertension . J. Hypertens.26 ( 2 ), 351 – 356 ( 2008 ).
- Lacourcière Y , ArnottW . Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients . J. Hum. Hypertens.8, 283 – 288 ( 1994 ).
- Mason RP , JacobRF, CorbalanJJ . The favourable kinetics and balance of nebivolol stimulated nitric oxide and peroxynitrite release in human endothelial cells . BMC Pharmacol. Toxicol.14, 48 ( 2013 ).
- Brixius K , MiddekeM, LichtenthalA . Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men . Clin. Exp. Pharmacol. Physiol.34, 327 – 331 ( 2007 ).
- James PA , OparilS, CarterBLet al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) . JAMA311 ( 5 ), 507 – 520 ( 2014 ).
- Leonetti G , EganCG . Use of carvedilol in hypertension: an update . Vasc. Health Risk Manag.8, 307 – 322 ( 2012 ).
- Weiss RN . A novel beta-blocker with nitric oxide-induced vasodilatation . Vasc. Health Risk Manag.2 ( 3 ), 303 – 308 ( 2006 ).
- Veldhuisen DJ , Cohen-SolalA, BöhmMet al. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with Heart Failure) . J. Am. Coll. Cardiol.53 ( 23 ), 2150 – 2158 ( 2009 ).